BackThe Real Brokerage Overview

The Real Brokerage Total Liabilities

Latest total liabilities for REAX: $91M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$91.33M
↑ 34.43% YoYΔ $23.39M vs prior year quarter

Peer average

Loading

The Real Brokerage Total Liabilities History

Loading

The Real Brokerage vs. peers: Total Liabilities Comparison

Loading

The Real Brokerage Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

The Real Brokerage (REAX) FAQ

As of the most recent data (March 2026), REAX shows a total liabilities of $91M. That compares with $68M in the prior-year period — up 34.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REAX's total liabilities is now $91M (was $68M) — a 34.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether The Real Brokerage is outperforming or lagging.

Tracking REAX's total liabilities over time shows whether The Real Brokerage is scaling, shrinking, or reshaping that part of the business. The current reading is $91M That compares with $68M in the prior-year period — up 34.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has The Real Brokerage's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $91M) with ownership activity and broader fundamentals.